No description
-
February 2011 (v1)Journal articleUploaded on: October 13, 2023
-
April 1, 2009 (v1)Journal article
Loss of tumor-suppressive pathways that control cellular senescence is a crucial step in malignant transformation. Spleen tyrosine kinase (Syk) is a cytoplasmic tyrosine kinase that has been recently implicated in tumor suppression of melanoma, a deadly skin cancer derived from pigment-producing melanocytes. However, the mechanism by which Syk...
Uploaded on: December 3, 2022 -
August 2, 2006 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
October 2003 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
March 1, 2000 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
April 17, 1998 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
April 14, 2004 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
September 1, 2005 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
February 1999 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
July 11, 2016 (v1)Journal article
Hepatitis B virus (HBV) is a small DNA virus that replicates by reverse transcription of a terminally redundant RNA, the pregenome. Specific packaging of this transcript into viral capsids is mediated by interaction of the reverse transcriptase, P protein, with the 5'-proximal encapsidation signal epsilon, epsilon-function is correlated with...
Uploaded on: February 28, 2023 -
June 2016 (v1)Journal article
We have discovered and developed a series of molecules (thiazole benzenesulfonamides). HA15, the lead compound of this series, displayed anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors. Our molecule displayed activity against other liquid and...
Uploaded on: February 28, 2023 -
July 4, 2005 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
December 2009 (v1)Journal article
no abstract
Uploaded on: December 4, 2022 -
May 4, 2017 (v1)Journal article
Metastatic melanoma is a deadly form of skin cancer. Extraordinary breakthroughs have been recently achieved in the treatment of the disease,1 leading to objective increase in patient survival. However, early detection of potential dangerous melanocytic lesions remains the best strategy to avoid metastatic dissemination, which is still the main...
Uploaded on: December 4, 2022 -
January 7, 2019 (v1)Journal article
no abstract
Uploaded on: December 4, 2022 -
December 2018 (v1)Journal article
No abstract available
Uploaded on: December 4, 2022 -
December 2020 (v1)Journal article
The clinical benefit of immune checkpoint inhibitory therapy (ICT) in advanced melanomas is limited by primary and acquired resistance. The molecular determinants of the resistance have been extensively studied, but these discoveries have not yet been translated into therapeutic benefits. As such, a paradigm shift in melanoma treatment, to...
Uploaded on: December 4, 2022 -
February 2011 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
2020 (v1)Journal article
Malignant melanoma is the most deadly form of skin cancer. It originates from melanocytic cells and can also arise at other body sites. Early diagnosis and appropriate medical care offer excellent prognosis with up to 5-year survival rate in more than 95% of all patients. However, long-term survival rate for metastatic melanoma patients remains...
Uploaded on: December 4, 2022